Funded Tech Companies
MyoPax
MyoPax, operating out of Berlin, received equity investments from IBB Ventures.
Company Overview
Company Name
MyoPax
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
c/o Bayer Co.Lab, Müllerstraße 178
Berlin, 13353
DE
Berlin, 13353
DE
Phone
Website
Email Address
Company Background Information
Overview
MyoPax is a spin-off from the Muscle Research Unit of the Charité Universitätsmedizin and the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association in Berlin (Website: Muscle Research Unit). Upon its launch in 2022, MyoPax joined the BioInnovation Institute in Copenhagen. We envisage becoming the international leader in biological muscle therapy. We have more than 30 years of relevant experience in human skeletal muscle research and development. We are passionate about our mission and determined to succeed. We are empowered by strong science, state-of-the-art technology and preeminent clinical expertise.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/4/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Verena Schöwel-Wolf
Co-Founder
Simone Spuler
Company Investors
Browse more funded tech companies:
Myonexus Therapeutics | Myosana Therapeutics
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs